| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/30/2013 | CN102895297A Preparation technology and production method for integrated new formulation of radix stephaniae tetrandrae and radix astragali decoction |
| 01/30/2013 | CN102895237A Application of Gypensapogenin A in drugs for resisting osteoporosis caused by estrogen deficiency |
| 01/30/2013 | CN102895210A Febuxostat tablet with improved dissolution rate |
| 01/30/2013 | CN102895209A Febuxostat tablet |
| 01/30/2013 | CN102406668B Preparation method of hypocrella bambusae extract |
| 01/30/2013 | CN102370807B Health-care snake medicated wine |
| 01/30/2013 | CN102370805B Snake medicated wine for enhancing strength |
| 01/30/2013 | CN102335189B Medicament composition containing antisense polynucleotide targeting miR-214 |
| 01/30/2013 | CN102327615B Bone targeting vector and medicament |
| 01/30/2013 | CN102266456B Medicament for treating orthopedic disease and preparation thereof |
| 01/30/2013 | CN102228441B Dexibuprofen sustained-release pellet and preparation method thereof |
| 01/30/2013 | CN102188508B Chinese medicine composition for treating knee osteoarthritis and preparation method thereof |
| 01/30/2013 | CN101780124B Capparis acutifolia sweet exact and preparation method and application thereof |
| 01/30/2013 | CN101229295B Bone regeneration pain-relieving plaster |
| 01/29/2013 | US8361962 Tricyclic inhibitors of JAK |
| 01/29/2013 | US8361485 Conditioned cell culture medium compositions and methods of use |
| 01/29/2013 | US8361467 Antagonist is selected from an antioxidant or an inhibitor of a pro-inflammatory interleukin, TNF- alpha synthesis, membrane-bound TNF- alpha, a natural receptor of TNF- alpha, nitric oxide synthase, phospholipase A2, apoptosis, matrix metalloproteases, or p38 kinase |
| 01/29/2013 | US8361443 Peptide-based compounds |
| 01/29/2013 | CA2522645C New monoclonal antibody capable of binding integrin alpha10beta1 |
| 01/29/2013 | CA2343929C Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 01/24/2013 | WO2013012644A1 2-methylene-20(21)-dehydro-19,24,25,26,27,-pentanor-vitamin d analogs |
| 01/24/2013 | WO2013011935A1 Therapeutic agent for bone fracture, bone growth enhancer, or therapeutic or prophylactic agent for bone diseases, each comprising carbon dioxide as active ingredient |
| 01/24/2013 | WO2013011514A1 Proteolytic extract from bromelain for the treatment of connective tissue disorders |
| 01/24/2013 | WO2013011063A1 Antagonistic antibodies against oscar |
| 01/24/2013 | WO2013011062A2 Oscar antagonists |
| 01/24/2013 | WO2013011061A1 Antagonistic antibodies against oscar |
| 01/24/2013 | WO2013011059A1 Antagonist antibodies against oscar |
| 01/24/2013 | WO2013011021A1 Use of c-fms antagonists |
| 01/24/2013 | WO2013010869A1 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk-inhibitors |
| 01/24/2013 | WO2013010868A1 4 - imidazopyridazin- 1 -yl-benzamides and 4 - imidazotriazin- 1 - yl - benzamides as btk- inhibitors |
| 01/24/2013 | WO2013010380A1 Btk inhibitors |
| 01/24/2013 | WO2012096494A9 Agent containing b-ring-substituted flavonoid derivatives for treating arthritis |
| 01/24/2013 | US20130023879 Method for augmenting, reducing, and repairing bone with thermoplastic materials (as amended) |
| 01/24/2013 | US20130023576 Pyrazole Compounds as CRTH2 Antagonists |
| 01/24/2013 | US20130023562 Novel piperidine derivatives |
| 01/24/2013 | US20130023556 Autotaxin inhibitors |
| 01/24/2013 | US20130023554 5-phenylpyrazolopyridine derivatives, preparation and therapeutic use thereof |
| 01/24/2013 | US20130023526 Isoxazolines as Therapeutic Agents |
| 01/24/2013 | US20130023521 Novel selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 01/24/2013 | US20130023517 Therapeutic methods employing substituted piperidines which are CCR3 antagonists |
| 01/24/2013 | US20130023514 Substituted pyrrolotriazines as protein kinase inhibitors |
| 01/24/2013 | US20130023512 Compositions for Combating Beta-Lactamase-Medicated Antibiotic Resistance Using Beta-Lactamase Inhibitors Useful For Injection |
| 01/24/2013 | US20130023504 Modulation of Prostaglandin/Cyclooxygenase Metabolic Pathways |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | US20130023497 Triazine Derivatives and their Therapeutical Applications |
| 01/24/2013 | US20130023494 Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| 01/24/2013 | US20130023485 Parenteral formulations of peptides for the treatment of systematic lupus erythematosus |
| 01/24/2013 | US20130023483 Template-fixed peptidomimetics with cxcr7 modulating activity |
| 01/24/2013 | US20130022661 Bio-remodable bone augmentation device and method |
| 01/24/2013 | US20130022642 Dual Antagonist for TNF-A and IL-21 for Preventing and Treating Autoimmune Diseases |
| 01/24/2013 | US20130022634 New composition and methods for treatment of autoimmune and allergic diseases |
| 01/24/2013 | US20130022617 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis |
| 01/24/2013 | US20130022613 Wise/sost nucleic acid sequences and amino acid sequences |
| 01/24/2013 | US20130022605 Antagonists against tnfr1 and methods of use therefor |
| 01/24/2013 | US20130022551 DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS |
| 01/24/2013 | CA2842330A1 Anti-fibrotic peptides and their use in methods for treating diseases and disorders characterized by fibrosis |
| 01/24/2013 | CA2842291A1 Proteolytic extract from bromelain for the treatment of connective tissue disorders |
| 01/24/2013 | CA2841899A1 Btk inhibitors |
| 01/24/2013 | CA2841887A1 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk - inhibitors |
| 01/24/2013 | CA2841886A1 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors |
| 01/24/2013 | CA2841013A1 Use of c-fms antagonists |
| 01/23/2013 | EP2548880A2 Compositions for increasing telomerase activity |
| 01/23/2013 | EP2548877A1 4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors |
| 01/23/2013 | EP2548866A1 New biologically active compound n-[3-(4-nitrophenylamino)-indol-2-ylmethylene]aminoguanidine hydrochloride with anti-inflammatory activity |
| 01/23/2013 | EP2548455A1 Equol-producing lactic acid bacteria-containing composition |
| 01/23/2013 | EP2548441A1 Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate |
| 01/23/2013 | EP2547700A1 Peptides or antibodies which bind to melanoma inhibitory activity (mia) protein |
| 01/23/2013 | EP2547662A1 Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 01/23/2013 | EP2547350A1 Compositions of rose hips enriched with seeds of rose hips and their use as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and joint diseases such as arthritis, rheumatoid arthritis and/or osteo-arthritis |
| 01/23/2013 | EP2547339A1 Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions |
| 01/23/2013 | CN102892776A Novel peptide and use thereof |
| 01/23/2013 | CN102892770A Trimethoxyphenyl inhibitors of tyrosine kinase |
| 01/23/2013 | CN102892759A Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 01/23/2013 | CN102887954A Human anti-il-23 antibodies, compositions, methods and uses |
| 01/23/2013 | CN102886037A Traditional Chinese medicine for treating senile knee joint degeneration and preparation method of traditional Chinese medicine |
| 01/23/2013 | CN102886034A Group of notopterygium root rheumatism pain tablets |
| 01/23/2013 | CN102886023A Prescription for treating rheumatism bone pain |
| 01/23/2013 | CN102886003A Traditional Chinese medicine composition for treating rheumatoid arthritis |
| 01/23/2013 | CN102886002A Traditional Chinese medicine composition for treating coxitis of dairy cattle and treatment method |
| 01/23/2013 | CN102885961A Medicine for treating rheumatic arthritis and rheumatoid arthritis and method for preparing medicine |
| 01/23/2013 | CN102885942A Chinese elder herb health-care white spirit for traumatic injury |
| 01/23/2013 | CN102885934A Medicament for treating rheumatoid arthritis |
| 01/23/2013 | CN102885828A Application of Gypensapogenin B in medicament for treating rheumatoid arthritis |
| 01/23/2013 | CN102885817A Application of 1,3-dicyclopentyl substituted Ectoin in preparing drug for treating rheumatoid arthritis |
| 01/23/2013 | CN102885759A Risedronate sodium sustained-release preparation and preparation method thereof |
| 01/23/2013 | CN102885304A BMD (bone mineral density)-increased health food composite and preparation method thereof |
| 01/23/2013 | CN102512574B Traditional Chinese medicine composition for treating animal rickets, its preparation method and its application |
| 01/23/2013 | CN102406654B Mineral substance crystal for regulating uric acid |
| 01/23/2013 | CN102397265B Method for preparing sinomenine hydrochloride membrane-controlled enteric controlled-release tablet |
| 01/23/2013 | CN102343027B Xianlinggubao extract, preparation containing same and preparation method thereof |
| 01/23/2013 | CN102309644B Traditional Chinese medical composition for treating bone fracture |
| 01/23/2013 | CN102240356B Powder for treating cervical spondylosis, intervertebral disc herniation, ankylosing spondylitis and hyperosteogeny |
| 01/23/2013 | CN102091051B Allopurinol dual-release preparation and preparation method thereof |
| 01/23/2013 | CN102020607B 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 01/23/2013 | CN101973922B Atorvastatin semi-strontium salt polymorphs as well as preparation and application thereof as HMG-CoA enzyme inhibitor |
| 01/23/2013 | CN101721531B Shendeng 4-decoction effective parts and preparation method thereof |
| 01/23/2013 | CN101641112B A novel combination of epimedium-derived-flavonoids-fractions for prevention of steroid-induced osteonecrosis |
| 01/23/2013 | CN101210244B Neutrokine-alpha and Neutrokine-alpha splice variants |
| 01/23/2013 | CN101023962B Western-Chinese medicine compounded preparation for treating gout |
| 01/22/2013 | US8357692 Methods of treatment of bone degenerative diseases |